# Establishing Effectiveness for Drugs Intended to Treat Male Hypogonadotropic Hypogonadism Attributed to Nonstructural Disorders Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/establishing-effectiveness-for-drugs-intended-to-treat-male-hypogonadotropic-hypogonadism-attributed-to-nonstructural-disorders-guidance-for-industry/45fa3246-6fd0-427b-9f31-dfee7ddb4a0a

> FDA guidance document: Establishing Effectiveness for Drugs Intended to Treat Male Hypogonadotropic Hypogonadism Attributed to Nonstructural Disorders Guidance for Industry. Issue date: May 18, 2018. Get complete insights and analysis.

---

## Details

- Title: Establishing Effectiveness for Drugs Intended to Treat Male Hypogonadotropic Hypogonadism Attributed to Nonstructural Disorders Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2018-05-18
- Last Changed: 2018-12-01

## Related Documents

- [Allergic Rhinitis: Developing Drug Products for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/allergic-rhinitis-developing-drug-products-for-treatment-guidance-for-industry/dcca7128-d84a-436f-83a2-e705904c701f)
- [Acne Vulgaris:  Establishing Effectiveness of Drugs Intended for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/acne-vulgaris-establishing-effectiveness-of-drugs-intended-for-treatment/513aaac8-5cc8-4e47-8797-621cd7679a08)
- [Migraine: Developing Drugs for Acute Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/migraine-developing-drugs-for-acute-treatment/39ba4b4b-6c93-4849-a087-866c6bf4edff)